Variable DM cohort Cross validation 80:20.
OR; 95% CI P value OR; 95% CI P value
Age 1.09; 1.04-1.15 0.000 1.12; 1.06-1.19 0.000
Ballooning 5.59; 2.69-11.61 0.000 7.01; 3.01-16.33 0.000
Use of Insulin 4.95; 1.65-14.88 0.004 4.64; 1.35-15.95 0.015
Use of Sulfonylurea 5.07; 1.87-13.75 0.001 4.63; 1.43-15.00 0.011
Use of Statins 0.31; 0.12-0.78 0.013 0.30; 0.10-0.86 0.025
Covariates included were age, BMI, gender, presence of hypertension, lipids, histology, use of insulin, metformin, sulfonylurea, statin and ACE-I/ARB. OR: Odds ratio, CI: Confidence interval.
Table 4: Independent risk factors of advanced fibrosis in DM subjects.